Company intelligence / Profile preview

Genesis Drug Discovery & Development

Hamilton, New Jersey, United Statesgd3services.com ↗

Ownership: Private
Development stage: Other

Overview

Genesis Drug Discovery & Development provides comprehensive preclinical CRO services spanning discovery biology through candidate selection. It offers expertise in synthetic organic/medicinal chemistry and disease modeling using advanced animal models including patient-derived xenografts. The company supports programs from early lead identification to IND-enabling studies for a wide range of therapeutic modalities and indications.

Therapeutic areas: OncologyMetabolic DisordersImmunologyGastroenterologyOphthalmology
Modalities: Small moleculeBiologicCell therapy
Industry: Contract Research Organization

Partnerships

Fox Chase Cancer Center (minority partner in NexusPharma)

Beyond the preview

Go deeper on Genesis Drug Discovery & Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genesis Drug Discovery & Development.

Explore the full profile